


Degron Therapeutics Revenue
Biotechnology Research • San Diego, California, United States • 11-20 Employees
Degron Therapeutics revenue & valuation
| Annual revenue | $1,200,000 |
| Revenue per employee | $71,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,900,000 |
| Total funding | No funding |
Key Contacts at Degron Therapeutics
Xiaoqi Liu
Senior Director, Business Development & Strategic Finance
I-Chung Lo
Associate Director Of Translational Science
Hai Ming Tang
Senior Director Of Toxicology
Siwei Victor
Director Of Dmpk
Yong Cang
Chief Scientific Officer And Co-Founder
Julia Dou
Director Of Protein Chemistry
Company overview
| Headquarters | 3210 Merryfield Row, San Diego, CA 92121, US |
| Phone number | +102161215873 |
| Website | |
| NAICS | 541714 |
| Keywords | Oncology, Inflammation, Metabolic, Molecular Glue Degrader Drugs |
| Founded | 2021 |
| Employees | 11-20 |
| Socials |
Degron Therapeutics Email Formats
Degron Therapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@degrontx.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@degrontx.com | 50% |
{first name}{last name} | johndoe@degrontx.com | 50% |
About Degron Therapeutics
Degron Therapeutics aims to become a global leader in the discovery and development of a new class of targeted protein degradation therapeutics, small molecule molecular glue degrader (MGD) drugs. Degron has assembled a team of world-class executives and scientific leaders, bringing its scientific excellence to the identification and validation of disease targets, particularly those undruggable by conventional small molecule inhibitors, and novel selective MGD compounds to meet unmet medical needs in all therapeutic areas.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Degron Therapeutics has 7 employees across 5 departments.
Departments
Number of employees
Funding Data
Degron Therapeutics has never raised funding before.
Degron Therapeutics Tech Stack
Discover the technologies and tools that power Degron Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Reverse proxies
Security
JavaScript libraries
UI frameworks
Frequently asked questions
4.8
40,000 users



